Senores Pharmaceuticals Limited (NSE:SENORES)
India · Delayed Price · Currency is INR 1,382.90
+3.00 (0.22%)
Sep 23, 2026, 3:29 PM IST
Senores Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 455.5 | 1,054 | 76.5 | 1 | 20.2 |
Short-Term Investments | - | 1,141 | 2,801 | 52.1 | - | 11.95 |
Cash & Short-Term Investments | 1,596 | 1,596 | 3,855 | 128.6 | 1 | 32.15 |
Cash Growth | -58.60% | -58.60% | 2897.67% | 12760.00% | -96.89% | - |
Accounts Receivable | - | 4,973 | 2,407 | 1,781 | 383.77 | 196.31 |
Other Receivables | - | 1.7 | 0.6 | - | - | - |
Receivables | - | 4,975 | 2,408 | 1,784 | 383.77 | 196.31 |
Inventory | - | 892.9 | 566.3 | 373.7 | 31.24 | 29.83 |
Prepaid Expenses | - | 155.2 | 72.1 | 30.3 | 12.02 | 0.14 |
Restricted Cash | - | - | - | 2 | - | - |
Other Current Assets | - | 505.1 | 322.8 | 190.5 | 85.34 | 12.09 |
Total Current Assets | - | 8,124 | 7,224 | 2,509 | 513.37 | 270.52 |
Property, Plant & Equipment | - | 3,627 | 2,524 | 1,791 | 152.64 | 61.16 |
Long-Term Investments | - | 61.9 | 13.3 | 194.9 | 168.54 | 155.48 |
Goodwill | - | 465.5 | 382.1 | 382.1 | - | - |
Other Intangible Assets | - | 3,388 | 1,826 | 1,152 | 464.43 | 88.42 |
Long-Term Deferred Tax Assets | - | - | 186.7 | 149.6 | - | 4.51 |
Other Long-Term Assets | - | 371.4 | 112.4 | 40 | 10.57 | 1.07 |
Total Assets | - | 16,038 | 12,269 | 6,219 | 1,311 | 591.52 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 2,347 | 672.2 | 1,130 | 135.82 | 71.36 |
Accrued Expenses | - | 92.3 | 90.1 | 80.5 | 10.68 | 2.12 |
Short-Term Debt | - | 331.9 | 312.2 | 323.9 | 81.57 | 19.91 |
Current Portion of Long-Term Debt | - | 1,028 | 1,111 | 823.4 | 228.74 | - |
Current Portion of Leases | - | 17.6 | 17.9 | 14.8 | 2.48 | 1.41 |
Current Income Taxes Payable | - | 202.3 | 134.9 | 71.1 | 15.85 | 1.28 |
Other Current Liabilities | - | 220.4 | 68.9 | 31.2 | 43.69 | 2.77 |
Total Current Liabilities | - | 4,240 | 2,407 | 2,475 | 518.83 | 98.85 |
Long-Term Debt | - | 1,949 | 1,625 | 1,337 | 297.32 | 122.16 |
Long-Term Leases | - | 131.8 | 82 | 77.8 | 15.83 | 4.07 |
Pension & Post-Retirement Benefits | - | 26.7 | 13.3 | 7.7 | 1.48 | 0.54 |
Long-Term Deferred Tax Liabilities | - | 5.9 | - | - | 20.96 | - |
Other Long-Term Liabilities | - | 39.4 | 19.2 | 4.7 | 1.12 | - |
Total Liabilities | - | 6,393 | 4,146 | 3,902 | 855.54 | 225.62 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 460.5 | 460.5 | 305.1 | 98.15 | 87.42 |
Additional Paid-In Capital | - | 6,765 | 6,551 | - | - | - |
Retained Earnings | - | 1,887 | 899.1 | 1,758 | 352.91 | 252.49 |
Comprehensive Income & Other | - | 224.3 | -48.3 | -20.5 | 3.93 | 25.99 |
Total Common Equity | 9,336 | 9,336 | 7,862 | 2,043 | 454.99 | 365.9 |
Minority Interest | - | 309.4 | 260.6 | 274.4 | - | - |
Shareholders' Equity | 9,645 | 9,645 | 8,123 | 2,317 | 454.99 | 365.9 |
Total Liabilities & Equity | - | 16,038 | 12,269 | 6,219 | 1,311 | 591.52 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 3,420 | 3,459 | 3,148 | 2,576 | 625.94 | 147.55 |
Net Cash (Debt) | -1,824 | -1,862 | 707.5 | -2,448 | -624.94 | -115.4 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -40.53 | -40.44 | 19.45 | -94.99 | -49.27 | -21.05 |
Filing Date Shares Outstanding | 46.48 | 46.05 | 46.05 | 33.27 | 9.82 | 9.82 |
Total Common Shares Outstanding | 46.48 | 46.05 | 46.05 | 30.5 | 9.82 | 9.82 |
Working Capital | - | 3,884 | 4,817 | 34.1 | -5.46 | 171.67 |
Book Value Per Share | 235.10 | 202.72 | 170.71 | 66.96 | 46.36 | 37.28 |
Tangible Book Value | 5,483 | 5,483 | 5,654 | 508.6 | -9.44 | 277.48 |
Tangible Book Value Per Share | 138.06 | 119.05 | 122.77 | 16.67 | -0.96 | 28.27 |
Land | - | 717.6 | 499.4 | 499.3 | 53.01 | 53.02 |
Buildings | - | 1,282 | 791.3 | 497.8 | - | - |
Machinery | - | 1,766 | 885.6 | 589.4 | 2.93 | 0.45 |
Construction In Progress | - | 174.6 | 441.7 | 177.7 | 80.55 | 3.46 |